83_FR_26811 83 FR 26700 - National Center for Advancing Translational Sciences; Notice of Closed Meeting

83 FR 26700 - National Center for Advancing Translational Sciences; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 111 (June 8, 2018)

Page Range26700-26701
FR Document2018-12402

Federal Register, Volume 83 Issue 111 (Friday, June 8, 2018) 
[Federal Register Volume 83, Number 111 (Friday, June 8, 2018)]
[Notices]
[Pages 26700-26701]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-12402]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special

[[Page 26701]]

Emphasis Panel; R13 Conference Grants Review.
    Date: July 10, 2018.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, Room 
1037, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Rahat Khan, Ph.D., Scientific Review Officer, 
Office of Scientific Review, National Center for Advancing 
Translational Sciences, 6701 Democracy Blvd., Rm 1078, Bethesda, MD 
20892, 301-594-7319, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: June 5, 2018.
 David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-12402 Filed 6-7-18; 8:45 am]
BILLING CODE 4140-01-P

26700 Federal Register / Vol. 83, No. 111 / Friday, June 8, 2018 / Notices more information about FDA’s posting the Federal Register concerning each communicable diseases. Under this of comments to public dockets, see 80 proposed collection of information, authority, FDA participates with State FR 56469, September 18, 2015, or access including each proposed extension of an regulatory agencies, some foreign the information at: https://www.gpo.gov/ existing collection of information, nations, and the molluscan shellfish fdsys/pkg/FR-2015-09-18/pdf/2015- before submitting the collection to OMB industry in the National Shellfish 23389.pdf. for approval. To comply with this Sanitation Program (NSSP). Docket: For access to the docket to requirement, FDA is publishing notice NSSP is a voluntary, cooperative read background documents or the of the proposed collection of program to promote the safety of electronic and written/paper comments information set forth in this document. molluscan shellfish by providing for the received, go to https:// With respect to the following collection of information, FDA invites classification and patrol of shellfish www.regulations.gov and insert the growing waters and for the inspection docket number, found in brackets in the comments on these topics: (1) Whether the proposed collection of information and certification of shellfish processors. heading of this document, into the Each participating State and foreign ‘‘Search’’ box and follow the prompts is necessary for the proper performance of FDA’s functions, including whether nation monitors its molluscan shellfish and/or go to the Dockets Management processors and issues certificates for Staff, 5630 Fishers Lane, Rm. 1061, the information will have practical utility; (2) the accuracy of FDA’s those that meet the State or foreign Rockville, MD 20852. shellfish control authority’s criteria. estimate of the burden of the proposed FOR FURTHER INFORMATION CONTACT: Ila collection of information, including the Each participating State and nation S. Mizrachi, Office of Operations, Food validity of the methodology and provides a certificate of its certified and Drug Administration, Three White assumptions used; (3) ways to enhance shellfish processors to FDA on Form Flint North, 10A–12M, 11601 the quality, utility, and clarity of the FDA 3038, ‘‘Interstate Shellfish Dealer’s Landsdown St., North Bethesda, MD information to be collected; and (4) Certificate.’’ FDA uses this information 20852, 301–796–7726, PRAStaff@ ways to minimize the burden of the to publish the ‘‘Interstate Certified fda.hhs.gov. collection of information on Shellfish Shippers List,’’ a monthly SUPPLEMENTARY INFORMATION: Under the respondents, including through the use comprehensive listing of all molluscan PRA (44 U.S.C. 3501–3520), Federal of automated collection techniques, shellfish processors certified under the Agencies must obtain approval from the when appropriate, and other forms of cooperative program. If FDA did not Office of Management and Budget information technology. collect the information necessary to (OMB) for each collection of compile this list, participating States Interstate Shellfish Dealer’s Certificate information they conduct or sponsor. would not be able to identify and keep ‘‘Collection of information’’ is defined OMB Control Number 0910–0021— out shellfish processed by uncertified in 44 U.S.C. 3502(3) and 5 CFR Extension processors in other States and foreign 1320.3(c) and includes Agency requests Under Section 243 of the Public nations. Consequently, NSSP would not or requirements that members of the Health Service Act (42 U.S.C. 243), FDA be able to control the distribution of public submit reports, keep records, or is required to cooperate with and aid uncertified and possibly unsafe shellfish provide information to a third party. State and local authorities in the in interstate commerce, and its Section 3506(c)(2)(A) of the PRA (44 enforcement of their health regulations effectiveness would be nullified. U.S.C. 3506(c)(2)(A)) requires Federal and are authorized to assist States in the FDA estimates the burden of this Agencies to provide a 60-day notice in prevention and suppression of collection of information as follows: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Number of Total Number of Average burden Activity FDA Form No. responses per annual Total hours respondents per response respondent responses Submission of Interstate Shell- 3038 40 57 2,280 0.10 (6 minutes) ............. 228 fish Dealer’s Certificate. 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Based on a review of the information Dated: June 4, 2018. amended, notice is hereby given of the collection since our last request for Leslie Kux, following meeting. OMB approval, we have made no Associate Commissioner for Policy. The meeting will be closed to the adjustments to our burden estimate. We [FR Doc. 2018–12340 Filed 6–7–18; 8:45 am] public in accordance with the estimate that 40 respondents will BILLING CODE 4164–01–P provisions set forth in sections submit 2,280 Interstate Shellfish 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Dealer’s Certificates annually, for a total as amended. The grant applications and burden of 228 hours (2,280 submissions DEPARTMENT OF HEALTH AND the discussions could disclose × 0.10 hours = 228 hours). This estimate HUMAN SERVICES confidential trade secrets or commercial is based on our experience with this property such as patentable material, amozie on DSK3GDR082PROD with NOTICES1 National Institutes of Health and personal information concerning information collection and the number individuals associated with the grant of certificates received in the past 3 National Center for Advancing applications, the disclosure of which years, which has remained constant. Translational Sciences; Notice of would constitute a clearly unwarranted Closed Meeting invasion of personal privacy. Pursuant to section 10(d) of the Name of Committee: National Center for Federal Advisory Committee Act, as Advancing Translational Sciences Special VerDate Sep<11>2014 16:53 Jun 07, 2018 Jkt 241001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\08JNN1.SGM 08JNN1

Federal Register / Vol. 83, No. 111 / Friday, June 8, 2018 / Notices 26701 Emphasis Panel; R13 Conference Grants This notice is being published less than 15 93.337, 93.393–93.396, 93.837–93.844, Review. days prior to the meeting due to the timing 93.846–93.878, 93.892, 93.893, National Date: July 10, 2018. limitations imposed by the review and Institutes of Health, HHS) Time: 1:00 p.m. to 5:00 p.m. funding cycle. Agenda: To review and evaluate grant Dated: June 4, 2018. Name of Committee: Center for Scientific applications. Review Special Emphasis Panel; PAR Sylvia L. Neal, Place: National Institutes of Health, One Review: Intervening with Caregivers and Program Analyst, Office of Federal Advisory Democracy Plaza, Room 1037, 6701 Integrated Cancer-Related Behavioral Committee Policy. Democracy Boulevard, Bethesda, MD 20892 Research. (Telephone Conference Call). [FR Doc. 2018–12401 Filed 6–7–18; 8:45 am] Date: June 29, 2018. Contact Person: Rahat Khan, Ph.D., Time: 2:00 p.m. to 6:30 p.m. BILLING CODE 4140–01–P Scientific Review Officer, Office of Scientific Agenda: To review and evaluate grant Review, National Center for Advancing applications. Translational Sciences, 6701 Democracy Place: National Institutes of Health, 6701 DEPARTMENT OF HEALTH AND Blvd., Rm 1078, Bethesda, MD 20892, 301– Rockledge Drive, Bethesda, MD 20892, 594–7319, khanr2@csr.nih.gov. HUMAN SERVICES (Virtual Meeting). (Catalogue of Federal Domestic Assistance Contact Person: John H. Newman, Ph.D., Program Nos. 93.859, Pharmacology, National Institutes of Health Scientific Review Officer, Center for Physiology, and Biological Chemistry Scientific Review, National Institutes of Research; 93.350, B—Cooperative National Institute on Alcohol Abuse Health, 6701 Rockledge Drive, Room 3222, Agreements; 93.859, Biomedical Research MSC 7808, Bethesda, MD 20892, (301) 435– and Alcoholism; Notice of Closed and Research Training, National Institutes of 0628, newmanjh@csr.nih.gov. Meeting Health, HHS) Name of Committee: Center for Scientific Dated: June 5, 2018. Review Special Emphasis Panel; Pursuant to section 10(d) of the David D. Clary, Fellowships: Risk, Prevention and Health Federal Advisory Committee Act, as Program Analyst, Office of Federal Advisory Behavior. amended, notice is hereby given of the Committee Policy. Date: July 9–10, 2018. following meeting. Time: 8:00 a.m. to 6:00 p.m. [FR Doc. 2018–12402 Filed 6–7–18; 8:45 am] Agenda: To review and evaluate grant The meeting will be closed to the BILLING CODE 4140–01–P applications. public in accordance with the Place: Embassy Suites at the Chevy Chase provisions set forth in sections Pavilion, 4300 Military Road NW, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., DEPARTMENT OF HEALTH AND Washington, DC 20015. as amended. The grant applications and HUMAN SERVICES Contact Person: Martha M. Faraday, Ph.D., the discussions could disclose Scientific Review Officer, Center for Scientific Review, National Institutes of confidential trade secrets or commercial National Institutes of Health Health, 6701 Rockledge Drive, Room 3110, property such as patentable material, Center for Scientific Review; Notice of MSC 7808, Bethesda, MD 20892, (301) 435– and personal information concerning Closed Meetings 3575, faradaym@csr.nih.gov. individuals associated with the grant Name of Committee: Center for Scientific applications, the disclosure of which Pursuant to section 10(d) of the Review Special Emphasis Panel; Secondary would constitute a clearly unwarranted Federal Advisory Committee Act, as Analyses of Existing Datasets in Heart, Lung, invasion of personal privacy. amended, notice is hereby given of the and Blood Diseases and Sleep Disorders. following meetings. Date: July 9–10, 2018. Name of Committee: National Institute on The meetings will be closed to the Time: 8:00 a.m. to 6:00 p.m. Alcohol Abuse and Alcoholism Special public in accordance with the Agenda: To review and evaluate grant Emphasis Panel; Alcohol Research Center provisions set forth in sections applications. Reviews (RFA AA18–001). 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: Lorien Hotel & Spa, 1600 King Date: July 26, 2018. Street, Alexandria, VA 22314. Time: 1:00 p.m. to 4:00 p.m. as amended. The grant applications and Contact Person: Delia Olufokunbi Sam, Agenda: To review and evaluate grant the discussions could disclose Ph.D., Scientific Review Officer, Center for confidential trade secrets or commercial applications. Scientific Review, National Institutes of Place: National Institutes of Health, property such as patentable material, Health, 6701 Rockledge Drive, Room 3158, and personal information concerning National Institute on Alcohol Abuse and MSC 7770, Bethesda, MD 20892, 301–435– Alcoholism, 6700B Rockledge Drive, individuals associated with the grant 0684, olufokunbisamd@csr.nih.gov. Bethesda, MD 20892 (Telephone Conference applications, the disclosure of which Name of Committee: Center for Scientific Call). would constitute a clearly unwarranted Review Special Emphasis Panel; Member Conflict: Neural Basis of Neurodegenerative Contact Person: Ranga Srinivas, Ph.D., invasion of personal privacy. Disorders and SCI. Chief, Extramural Project Review Branch, Name of Committee: Center for Scientific National Institute on Alcohol Abuse and Date: July 9, 2018. Review Special Emphasis Panel; CNBT Study Alcoholism, National Institutes of Health, Time: 11:00 a.m. to 2:00 p.m. Section Special Emphasis Panel. Agenda: To review and evaluate grant 5365 Fishers Lane, Room 2085, Rockville, Date: June 7, 2018. applications. MD 20852, (301) 451–2067, srinivar@ Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant Place: National Institutes of Health, 6701 mail.nih.gov. applications. Rockledge Drive, Bethesda, MD 20892, (Catalogue of Federal Domestic Assistance Place: Embassy Suites at the Chevy Chase (Virtual Meeting). Program Nos. 93.271, Alcohol Research Pavilion, 4300 Military Road NW, Contact Person: Paula Elyse Schauwecker, Career Development Awards for Scientists amozie on DSK3GDR082PROD with NOTICES1 Washington, DC 20015. Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific and Clinicians; 93.272, Alcohol National Contact Person: Samuel C. Edwards, Ph.D., Review, 6701 Rockledge Drive, Room 5211, Research Service Awards for Research Chief, Brain Disorders and Clinical Neuroscience, Center for Scientific Review, Bethesda, MD 20892, 301–760–8207, Training; 93.273, Alcohol Research Programs; National Institutes of Health, 6701 Rockledge schauweckerpe@csr.nih.gov. 93.891, Alcohol Research Center Grants; Drive, Room 5210, MSC 7846, Bethesda, MD (Catalogue of Federal Domestic Assistance 93.701, ARRA Related Biomedical Research 20892, (301) 435–1246, edwardss@ Program Nos. 93.306, Comparative Medicine; and Research Support Awards, National csr.nih.gov. 93.333, Clinical Research, 93.306, 93.333, Institutes of Health, HHS) VerDate Sep<11>2014 16:53 Jun 07, 2018 Jkt 241001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\08JNN1.SGM 08JNN1


Document Created: 2018-06-08 01:23:03
Document Modified: 2018-06-08 01:23:03
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJuly 10, 2018.
FR Citation83 FR 26700 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR